NasdaqCM - Nasdaq Real Time Price USD
Lyra Therapeutics, Inc. (LYRA)
Tune into live earnings calls Now streaming directly on quote pages.
0.0925
-0.0057
(-5.80%)
As of 2:27:42 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -0.1 | -0.1 | -0.42 | 0 |
| Low Estimate | -0.1 | -0.1 | -0.42 | 0 |
| High Estimate | -0.1 | -0.1 | -0.42 | 0 |
| Year Ago EPS | -0.26 | -0.14 | -0.89 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 4 | 2 |
| Avg. Estimate | 440k | 440k | 860.25k | 3.87M |
| Low Estimate | 440k | 440k | -- | 398k |
| High Estimate | 440k | 440k | 1.54M | 7.34M |
| Year Ago Sales | 598k | 195k | 1.53M | 860.25k |
| Sales Growth (year/est) | -26.42% | 125.64% | -43.92% | 349.87% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.33 | -0.2 | -0.13 | -0.14 |
| EPS Actual | -0.26 | -0.14 | -0.14 | -0.13 |
| Difference | 0.07 | 0.07 | -0.01 | 0.01 |
| Surprise % | 21.04% | 32.44% | -9.15% | 4.88% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.1 | -0.1 | -0.42 | 0 |
| 7 Days Ago | 0 | 0 | -1 | 0 |
| 30 Days Ago | 0 | 0 | -1 | 0 |
| 60 Days Ago | 0 | 0 | -0.94 | 0 |
| 90 Days Ago | 0 | 0 | -0.94 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LYRA | 61.39% | 27.80% | 52.70% | -- |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 3/14/2025 |
| Reiterates | Cantor Fitzgerald: Overweight | 8/15/2024 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 8/15/2024 |
| Reiterates | Cantor Fitzgerald: Overweight | 6/20/2024 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 5/7/2024 |
| Downgrade | Jefferies: Buy to Hold | 5/7/2024 |
Related Tickers
ONCO Onconetix, Inc.
0.0705
-2.08%
PTIX Protagenic Therapeutics, Inc.
2.9500
-5.14%
PCSA Processa Pharmaceuticals, Inc.
0.2391
+0.04%
ZVSA ZyVersa Therapeutics, Inc.
0.5217
-1.04%
TNFA TNF Pharmaceuticals, Inc.
0.1895
-0.26%
HEPA Hepion Pharmaceuticals, Inc.
0.3375
-13.76%
SPRC SciSparc Ltd.
0.3585
+6.22%
CYCC Cyclacel Pharmaceuticals, Inc.
3.8030
-6.20%
GBIO Generation Bio Co.
0.3943
+9.53%
ASMB Assembly Biosciences, Inc.
12.31
+0.54%